Ironwood Pharmaceuticals Leadership Change
Ironwood Pharmaceuticals appointed Tammi Gaskins, currently Senior Vice President and Chief Commercial Officer, as Chief Executive Officer and a director, effective January 1, 2027. She succeeds Thomas McCourt, who will retire as CEO on December 31, 2026, after 17 years with the company but will remain on the Board of Directors. Gaskins will receive an annual base salary of $775,000 and $4 million in target equity grant value as part of her new role.